Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.190
+0.060 (1.92%)
Dec 20, 2024, 4:00 PM EST - Market closed
Atea Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | - | - | - | 351.37 | 48.63 | - | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 622.49% | - | - | Upgrade
|
| Cost of Revenue | 78.28 | 70.09 | 62.39 | 167.21 | 38.02 | 10.17 | Upgrade
|
| Gross Profit | -78.28 | -70.09 | -62.39 | 184.16 | 10.61 | -10.17 | Upgrade
|
| Selling, General & Admin | 47.02 | 49.92 | 48.71 | 45.79 | 21.64 | 4.44 | Upgrade
|
| Operating Expenses | 47.02 | 49.92 | 48.71 | 45.79 | 21.64 | 4.44 | Upgrade
|
| Operating Income | -125.3 | -120.01 | -111.1 | 138.38 | -11.03 | -14.61 | Upgrade
|
| Interest & Investment Income | 27.54 | 29.22 | 11.15 | 0.21 | 0.08 | 0.57 | Upgrade
|
| EBT Excluding Unusual Items | -97.76 | -90.79 | -99.95 | 138.59 | -10.95 | -14.03 | Upgrade
|
| Other Unusual Items | -75.2 | -44.15 | -19.55 | - | - | - | Upgrade
|
| Pretax Income | -172.96 | -134.94 | -119.5 | 138.59 | -10.95 | -14.03 | Upgrade
|
| Income Tax Expense | 1.05 | 1.02 | -3.59 | 17.4 | - | - | Upgrade
|
| Net Income | -174.01 | -135.96 | -115.91 | 121.19 | -10.95 | -14.03 | Upgrade
|
| Net Income to Common | -174.01 | -135.96 | -115.91 | 121.19 | -10.95 | -14.03 | Upgrade
|
| Shares Outstanding (Basic) | 84 | 83 | 83 | 83 | 22 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 84 | 83 | 83 | 88 | 22 | 10 | Upgrade
|
| Shares Change (YoY) | 0.79% | 0.17% | -5.67% | 308.70% | 113.98% | 0.52% | Upgrade
|
| EPS (Basic) | -2.07 | -1.63 | -1.39 | 1.46 | -0.51 | -1.39 | Upgrade
|
| EPS (Diluted) | -2.07 | -1.63 | -1.39 | 1.37 | -0.51 | -1.39 | Upgrade
|
| Free Cash Flow | -126.94 | -85.4 | -122.93 | -87.01 | 296.71 | -12.83 | Upgrade
|
| Free Cash Flow Per Share | -1.51 | -1.02 | -1.48 | -0.99 | 13.74 | -1.27 | Upgrade
|
| Gross Margin | - | - | - | 52.41% | 21.82% | - | Upgrade
|
| Operating Margin | - | - | - | 39.38% | -22.68% | - | Upgrade
|
| Profit Margin | - | - | - | 34.49% | -22.51% | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | -24.76% | 610.10% | - | Upgrade
|
| EBITDA | -124.88 | -119.59 | -110.84 | 138.41 | -11.01 | -14.59 | Upgrade
|
| EBITDA Margin | - | - | - | 39.39% | -22.64% | - | Upgrade
|
| D&A For EBITDA | 0.42 | 0.42 | 0.26 | 0.03 | 0.02 | 0.02 | Upgrade
|
| EBIT | -125.3 | -120.01 | -111.1 | 138.38 | -11.03 | -14.61 | Upgrade
|
| EBIT Margin | - | - | - | 39.38% | -22.68% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 12.55% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.